Skip to main content
SpringerLink
Log in

Tamoxifen: risk of endometrial cancer in postmenopausal women

  • Unknown
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. including bloody vaginal discharge, staining or spotting

Reference

  • Committee on Gynecologic Practice. Committee Opinion No. 601: Tamoxifen and Uterine Cancer. Obstetrics and Gynecology 123: 1394-1397, No. 6, Jun 2014

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tamoxifen: risk of endometrial cancer in postmenopausal women. Reactions Weekly 1507, 3 (2014). https://doi.org/10.1007/s40278-014-1527-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1527-9

Search

Navigation